Cytomos unveils new brand and revamped website
Biotech company Cytomos has announced the creation of its newly named AuraCyt cell analysis technology brand and the launch of its improved website.
Source: biopharma-reporter.com
Page 21 - Bio Developments News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Bio Developments. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Bio Developments Today - Breaking & Trending Today
BioSenic secures key funding as it pushes for phase 3 trial
Biosenic, a company specializing in serious autoimmune and inflammatory diseases and cell therapy, has secured funding from Singapore-based TrialCap, in a bid to accelerate its phase 3 clinical development.
Source: biopharma-reporter.com
Microbiome-based treatment shows potential in graft-versus-host disease
MaaT Pharma, a clinical-stage biotech company developing microbiome ecosystem therapies, has presented positive results from a recent study investigating its lead product MaaT013 for patients with steroid-refractory (SR) or steroid-dependent (SD) gastrointestinal acute graft-versus-host Disease (GI-aGvHD).
Source: biopharma-reporter.com
Eligo Bioscience forges ahead with new acne treatment after $30 million investment
Eligo Bioscience, a gene-editing company focused on addressing diseases driven by the expression of bacterial genes from the microbiome, has announced a successful $30 million Series B funding round, led by Sanofi Ventures.
Source: biopharma-reporter.com
Obesity drug Mounjaro to surpass Ozempic with $27 billion sales in 2029
Novo Nordisk's Ozempic (semaglutide) took the weight loss sector by storm in 2023, propelled by strong efficacy and safety data, coupled with social media buzz and celebrity endorsements that elevated the drug to mainstream prominence.
Source: biopharma-reporter.com